<DOC>
	<DOC>NCT00615251</DOC>
	<brief_summary>This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will be approximately 12 months and will involve ovarian suppression/stimulation protocols as well as egg retrieval.</brief_summary>
	<brief_title>A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Premenopausal, aged 1842 old at time of consent At least one cycle without fertility medication prior to screening Tubal, idiopathic, male factor, ovulatory dysfunction or endometriosis linked infertility Semen analysis (frozen sperm, including donor sperm, may be used, as long as testing done at time of freezing meets standard criteria) Others as indicated by FDAapproved protocol Any contraindication to progesterone therapy BMI &gt; 38 kg/m2 Clinically significant gynecologic pathology (for example: submucosal fibroids, abnormal uterine cavity, or others) History of more than 1 failed fresh IVF cycles More than 2 consecutive clinical miscarriages (gestational sac observed on ultrasound) Others as indicated by FDAapproved protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>In vitro fertilization</keyword>
</DOC>